Published in Br J Ind Med on May 01, 1988
Environmental exposure to benzene: an update. Environ Health Perspect (1996) 1.59
Breath measurements as volatile organic compound biomarkers. Environ Health Perspect (1996) 1.20
Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Br J Ind Med (1993) 1.01
Environmental and biological monitoring of benzene during self-service automobile refueling. Environ Health Perspect (2000) 0.94
Benzene and naphthalene in air and breath as indicators of exposure to jet fuel. Occup Environ Med (2003) 0.94
Volatile organic compounds as breath biomarkers for active and passive smoking. Environ Health Perspect (2002) 0.93
Exposure of petrol station attendants and auto mechanics to premium motor sprit fumes in Calabar, Nigeria. J Environ Public Health (2009) 0.89
Exposure to benzene in urban workers: environmental and biological monitoring of traffic police in Rome. Occup Environ Med (2001) 0.89
Benzene toxicokinetics in humans: exposure of bone marrow to metabolites. Occup Environ Med (1994) 0.85
The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit Rev Toxicol (2013) 0.83
Evaluation of biomarkers for occupational exposure to benzene. Occup Environ Med (1995) 0.83
Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile organic compounds (VOCs). Environ Health Perspect (1995) 0.81
Biological monitoring of occupational exposure to tetrahydrofuran. Br J Ind Med (1991) 0.80
Biomarkers of environmental benzene exposure. Environ Health Perspect (1996) 0.79
Determination of low level exposure to volatile aromatic hydrocarbons and genotoxic effects in workers at a styrene plant. Occup Environ Med (1995) 0.79
Trichloroethylene [correction of Trichloroethene] levels in human blood and exhaled breath from controlled inhalation exposure. Environ Health Perspect (1998) 0.75
Radiological changes after withdrawal from asbestos exposure. Br J Ind Med (1979) 1.70
Simulation and prediciton of uptake, distribution, and exhalation of organic solvents. Br J Ind Med (1974) 1.50
Determination and prediction of tissue-gas partition coefficients. Int Arch Occup Environ Health (1986) 1.34
Ostwald solubility coefficients of some industrially important substances. Br J Ind Med (1976) 1.20
Breath concentration as an index of the health risk from benzene. Studies on the accumulation and clearance of inhaled benzene. Scand J Work Environ Health (1980) 1.15
Benzene: pharmacokinetic studies in man. Ann Occup Hyg (1972) 0.98
Low level benzene exposure in Sweden: effect on blood elements and body burden of benzene. Am J Ind Med (1985) 0.94
A study of benzene exposure versus urinary phenol levels. Am Ind Hyg Assoc J (1977) 0.93
Benzene: standards, occurrence, and exposure. Am J Ind Med (1985) 0.92
Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88
Absorption and elimination of inhaled benzene in man. Arch Ind Hyg Occup Med (1950) 0.87
Respiratory retention of inhaled toluene and benzene in the dog. J Toxicol Environ Health (1976) 0.85
A method for the determination of low concentrations of organic vapours in air and exhaled breath. Ann Occup Hyg (1977) 0.84
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients. Nutrition (1995) 1.41
Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med (1985) 1.32
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG) Ann Oncol (1999) 1.24
Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health (1978) 1.16
Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br J Cancer (2009) 1.13
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br J Cancer (2004) 1.13
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer (2004) 1.11
Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health (1979) 1.10
The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant (2001) 1.08
The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer (2002) 1.07
Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med (1986) 1.03
Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health (1980) 1.02
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration. Int J Cancer Suppl (1994) 1.00
Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health (1984) 0.99
A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer (1991) 0.99
Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health (1977) 0.99
Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. Eur J Surg Oncol (2003) 0.98
The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites. Pharmacol Biochem Behav (2002) 0.98
Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol (1980) 0.97
Benzene in the blood and breath of normal people and occupationally exposed workers. Am J Ind Med (1989) 0.97
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. Br J Cancer (1991) 0.96
Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol (1982) 0.95
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg (2006) 0.95
Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health (1979) 0.94
Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health (1980) 0.94
Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. Br J Cancer (2013) 0.94
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg (2002) 0.94
The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology (2001) 0.93
Where is West Nile fever? Lessons learnt from recent human cases in northern Italy. Euro Surveill (2009) 0.93
Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. Thorax (1980) 0.93
[2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav (1985) 0.93
Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol (1981) 0.92
The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health (1985) 0.90
Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health (1982) 0.90
Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health (1981) 0.90
Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88
High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours. J Pathol (1997) 0.88
Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol (1994) 0.87
Decreased cardiopulmonary reflexes with aging in normotensive humans. Am J Physiol (1989) 0.87
"Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model. Am Ind Hyg Assoc J (1990) 0.87
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia. Leukemia (2013) 0.87
An improved method of analysing 2,5-hexanedione in urine. Br J Ind Med (1990) 0.86
[Survey of Phlebotomus neglectus Tonnoir, 1921 (=P. major s.l.) in a leishmaniasis focus in northern Italy (province of Verona)]. Parassitologia (1995) 0.86
[Gas chromatographic determination of 2,5-hexanedione in the urine]. Med Lav (1987) 0.86
Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int Arch Occup Environ Health (1989) 0.86
Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis (1993) 0.86
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. Br J Surg (2004) 0.86
Metabolic processing of gangliosides by human fibroblasts in culture--formation and recycling of separate pools of sphingosine. Eur J Biochem (1997) 0.85
Alveolar air and blood toluene concentration in rotogravure workers. Int Arch Occup Environ Health (1976) 0.85
Ethylene oxide exposure. Biological monitoring by analysis of alveolar air and blood. Int Arch Occup Environ Health (1986) 0.85
Metabolic interaction between n-hexane and toluene in vivo and in vitro. Int Arch Occup Environ Health (1982) 0.85
Primary cardiac leiomyosarcoma: seven-year survival with combined surgical and adjuvant therapy. Int J Cardiol (1997) 0.84
Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center. Ann Surg Oncol (2012) 0.84
Decline of blood and alveolar toluene concentration following two accidental human poisonings. Int Arch Occup Environ Health (1983) 0.84
The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. Br J Cancer (2002) 0.84
The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy. Vaccine (2005) 0.83
Sentinel node biopsy in breast cancer. Breast (2000) 0.83
Gram-negative septicemia in patients with hematologic malignancies. Eur J Cancer Clin Oncol (1984) 0.83
[Urban air pollutant exposure among traffic policemen]. Med Lav (1997) 0.83
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study. Ann Oncol (1999) 0.83
Biochemical and physiological aspects of 2,5-hexanedione: endogenous or exogenous product? Int Arch Occup Environ Health (1993) 0.82
Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res (2000) 0.82
[Behavior of urinary D-glucaric acid in occupational exposure to inorganic lead]. Med Lav (1988) 0.82
Hippuric acid and ortho-cresol as biological indicators of occupational exposure to toluene. Am J Ind Med (1987) 0.82
Specific ganglioside-cell protein interactions: a study performed with GM1 ganglioside derivative containing photoactivable azide and rat cerebellar granule cells in culture. Neurochem Int (1992) 0.81
Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol (2002) 0.81
Neurotoxic metabolites of "commercial hexane" in the urine of shoe factory workers. Clin Toxicol (1981) 0.81
[Acute poisoning with carbon dioxide: report of 2 fatal cases]. Med Lav (2002) 0.79
Acute arsine intoxication as a consequence of metal burnishing operations. Am J Ind Med (1997) 0.79
Formation of a cytosolic ganglioside-protein complex following administration of photoreactive ganglioside GM1 to human fibroblasts in culture. FEBS Lett (1990) 0.79
Prevention and monitoring of adverse events following immunization: the "Green Channel" of the Veneto region in Italy. Vaccine (2003) 0.79
Concentration of ethylene oxide in the alveolar air of occupationally exposed workers. Am J Ind Med (1985) 0.79
Reference values for blood toluene in the occupationally nonexposed general population. Int Arch Occup Environ Health (1993) 0.79
Identification of the n-heptane metabolites in rat and human urine. Arch Toxicol (1986) 0.79
HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis (1999) 0.79
[Health aspects of antibiotic manufacture with particular emphasis on respiratory and genital disturbances (author's transl)]. Lav Um (1977) 0.78
Positive end-expiratory pressure applied to the dependent lung during one-lung ventilation improves oxygenation and respiratory mechanics in patients with high FEV1. Eur J Anaesthesiol (2004) 0.78
Effects of different immunolabeling techniques on the detection of small-cell lung cancer cells in bone marrow. J Histochem Cytochem (1999) 0.78
Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2,3-dihydro-4H-1-benzopyrans and -benzothiopyrans. J Med Chem (1990) 0.78
Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery. Cytometry B Clin Cytom (2009) 0.78
N-N-dimethylformamide concentration in environmental and alveolar air in an artificial leather factory. Br J Ind Med (1980) 0.78
Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int Arch Occup Environ Health (1993) 0.78
Intestinal permeability in patients with atopic eczema. Br J Dermatol (1989) 0.78
[Overcoming mandatory vaccination policy: first steps]. Ann Ig (2008) 0.78
Formation of tritium-labeled polysialylated gangliosides in the cytosol of rat cerebellar granule cells in culture following administration of [3H]GM1 ganglioside. FEBS Lett (1990) 0.77
Relationship between the regulation of membrane enzyme activities by gangliosides and a possible ganglioside segregation in membrane microdomains. Indian J Biochem Biophys (1990) 0.77
Isopropanol exposure: environmental and biological monitoring in a printing works. Br J Ind Med (1983) 0.77
Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients. Br J Cancer (1999) 0.77